Biotricity Stock (NASDAQ:BTCY)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$0.28

52W Range

$0.19 - $1.67

50D Avg

$0.33

200D Avg

$0.81

Market Cap

$7.68M

Avg Vol (3M)

$69.01K

Beta

1.23

Div Yield

-

BTCY Company Profile


Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

55

IPO Date

Feb 16, 2018

Website

BTCY Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceMar 24
Device Sales-

Fiscal year ends in Mar 24 | Currency in USD

BTCY Financial Summary


Mar 24Mar 23Mar 22
Revenue---
Operating Income---
Net Income---
EBITDA---
Basic EPS---
Diluted EPS---

Fiscal year ends in Mar 24 | Currency in USD

Latest Earnings Call Transcripts


Q2 25Nov 15, 24 | 8:24 PM
Q4 24Jun 27, 24 | 6:40 PM
Q3 24Feb 21, 24 | 7:02 PM

Peer Comparison


TickerCompany
BMRABiomerica, Inc.
AIMDAinos, Inc.
INVOINVO Bioscience, Inc.
NSYSNortech Systems Incorporated
DCTHDelcath Systems, Inc.
NVNOenVVeno Medical Corporation
MOVEMovano Inc.
CLPTClearPoint Neuro, Inc.
BSGMBioSig Technologies, Inc.
MODDModular Medical, Inc.
TELATELA Bio, Inc.
SRDXSurmodics, Inc.
MXCTMaxCyte, Inc.
PAVMPAVmed Inc.
BBLGBone Biologics Corporation
NARIInari Medical, Inc.
BJDXBluejay Diagnostics, Inc.
HSCSHeart Test Laboratories, Inc.
CVRXCVRx, Inc.